Tags

Type your tag names separated by a space and hit enter

Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study.
BMC Endocr Disord. 2015 Aug 26; 15:44.BE

Abstract

BACKGROUND

Insulinomas, which are rare tumors causing hyperinsulinemic hypoglycemia are usually sporadic but may also occur in association with multiple endocrine neoplasia type 1 (MEN-1) syndrome an autosomal dominant disorder caused by MEN1 gene mutations. MEN1 encodes a nuclear protein Menin, a tumor suppressor which acts as an adapter and interacts with partner proteins involved in crucial activities like transcriptional regulation, cell division, proliferation and genome stability. This study reports on clinical findings and mutation screening in sporadic insulinoma patients.

METHODS

Seventeen patients diagnosed with insulinoma were recruited along with 30 healthy volunteers who acted as controls for the present study. The patients presented with symptoms of sweating, tremors, drowsiness, palpitations, loss of consciousness, abnormal behavior, seizures and weight gain. Detailed clinical and family history was collected from all the participants along with 5 ml of blood sample after taking informed consent. Genomic DNA isolated from blood was subjected to MEN1 gene amplification followed by direct sequencing. Nucleotide sequences obtained were compared with published MEN1 cDNA sequences. Prediction of functional effects of novel changes was done using various bioinformatics algorithms.

RESULTS

Molecular analysis revealed presence of three novel exonic mutations (M561K, Q192K and Q261Q), two novel intronic variations c.445-44G → A and c.913-42G → C in introns two and six respectively and three reported exon SNPs; H433H (rs540012), D418D (rs2071313), A541T (rs2959656) and one intronic SNP (rs669976).

CONCLUSIONS

The study identified presence of novel pathogenic MEN1 mutations in sporadic cases of insulinoma. The new mutations identified were in regions involved in defective binding of menin to proteins implicated in genetic and epigenetic mechanisms. The outcome of the study extends the growing list of MEN1 pathogenic mutations even in sporadic cases providing consequential insight into phenotypic heterogeneity and in the expression of individual mutations.

Authors+Show Affiliations

Department of Endocrinology and metabolism, All India Institute of Medical Sciences, Room No. 305, Third Floor, Biotechnology Building, New Delhi, India. vivekapjyotsna@gmail.com.Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India. malikekta86@gmail.com.Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India. sbirla84@gmail.com.Department of Anatomy, All India Institute of Medical Sciences, New Delhi, India. arundhatisharma1@gmail.com.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26307114

Citation

Jyotsna, Viveka P., et al. "Novel MEN 1 Gene Findings in Rare Sporadic Insulinoma--a Case Control Study." BMC Endocrine Disorders, vol. 15, 2015, p. 44.
Jyotsna VP, Malik E, Birla S, et al. Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study. BMC Endocr Disord. 2015;15:44.
Jyotsna, V. P., Malik, E., Birla, S., & Sharma, A. (2015). Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study. BMC Endocrine Disorders, 15, 44. https://doi.org/10.1186/s12902-015-0041-2
Jyotsna VP, et al. Novel MEN 1 Gene Findings in Rare Sporadic Insulinoma--a Case Control Study. BMC Endocr Disord. 2015 Aug 26;15:44. PubMed PMID: 26307114.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study. AU - Jyotsna,Viveka P, AU - Malik,Ekta, AU - Birla,Shweta, AU - Sharma,Arundhati, Y1 - 2015/08/26/ PY - 2014/12/10/received PY - 2015/08/21/accepted PY - 2015/8/27/entrez PY - 2015/8/27/pubmed PY - 2016/3/8/medline SP - 44 EP - 44 JF - BMC endocrine disorders JO - BMC Endocr Disord VL - 15 N2 - BACKGROUND: Insulinomas, which are rare tumors causing hyperinsulinemic hypoglycemia are usually sporadic but may also occur in association with multiple endocrine neoplasia type 1 (MEN-1) syndrome an autosomal dominant disorder caused by MEN1 gene mutations. MEN1 encodes a nuclear protein Menin, a tumor suppressor which acts as an adapter and interacts with partner proteins involved in crucial activities like transcriptional regulation, cell division, proliferation and genome stability. This study reports on clinical findings and mutation screening in sporadic insulinoma patients. METHODS: Seventeen patients diagnosed with insulinoma were recruited along with 30 healthy volunteers who acted as controls for the present study. The patients presented with symptoms of sweating, tremors, drowsiness, palpitations, loss of consciousness, abnormal behavior, seizures and weight gain. Detailed clinical and family history was collected from all the participants along with 5 ml of blood sample after taking informed consent. Genomic DNA isolated from blood was subjected to MEN1 gene amplification followed by direct sequencing. Nucleotide sequences obtained were compared with published MEN1 cDNA sequences. Prediction of functional effects of novel changes was done using various bioinformatics algorithms. RESULTS: Molecular analysis revealed presence of three novel exonic mutations (M561K, Q192K and Q261Q), two novel intronic variations c.445-44G → A and c.913-42G → C in introns two and six respectively and three reported exon SNPs; H433H (rs540012), D418D (rs2071313), A541T (rs2959656) and one intronic SNP (rs669976). CONCLUSIONS: The study identified presence of novel pathogenic MEN1 mutations in sporadic cases of insulinoma. The new mutations identified were in regions involved in defective binding of menin to proteins implicated in genetic and epigenetic mechanisms. The outcome of the study extends the growing list of MEN1 pathogenic mutations even in sporadic cases providing consequential insight into phenotypic heterogeneity and in the expression of individual mutations. SN - 1472-6823 UR - https://www.unboundmedicine.com/medline/citation/26307114/Novel_MEN_1_gene_findings_in_rare_sporadic_insulinoma__a_case_control_study_ L2 - https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-015-0041-2 DB - PRIME DP - Unbound Medicine ER -